CDMO
Avid Bioservices, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website avidbio.com
- Employees(FY) 365
- ISIN US05368M1062
Performance
+12.04%
1W
+25.79%
1M
+21.6%
3M
+76.06%
6M
+40.31%
YTD
-40.04%
1Y
Profile
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services of biologics for the biotechnology and biopharmaceutical industries. The company offers various services, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.
Investment Analysis Report: CDMO
Overview:
CDMO is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $474.29 million. In this report, we will conduct a detailed analysis of CDMO's financial health, valuation, earnings and revenue growth, profitability, oper...
Technical Analysis of CDMO 2024-05-10
Overview:
In analyzing the technical indicators for CDMO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average (MA) has been consistently above the c...
Recent News & Updates
- 2024-05-08 00:26
Hidden Gems: Unveiling the 10 Stocks on Hedge Funds' Radar(Insidermonkey)
- 2024-05-07 16:05
- 2024-05-07 04:05
- 2024-05-03 04:17
How Novo-Catalent Deal Affects Halozyme (HALO)?(Insider Monkey)
- 2024-05-02 16:17
How Novo-Catalent Deal Affects Halozyme (HALO)?(Insidermonkey)
- 2024-05-02 15:31
- 2024-05-02 14:44
- 2024-04-30 06:48
Q3 2024 Avid Bioservices Inc Earnings Call(Thomson Reuters StreetEvents)
- 2024-04-30 03:05
- 2024-04-25 02:46
- 2024-04-24 17:39
Avid Bioservices: Fiscal Q3 Earnings Snapshot(Associated Press Finance)
- 2024-04-24 17:25
- 2024-04-24 10:52
- 2024-04-24 05:25
- 2024-04-10 00:46
- 2024-04-01 03:07
- 2024-03-28 00:51
- 2024-03-21 02:27
- 2024-03-20 07:00
- 2024-03-19 19:00
- 2024-03-14 00:30
- 2024-03-11 07:08
- 2024-03-10 09:01
- 2024-03-07 01:59
- 2024-03-06 23:58
- 2024-03-06 20:05
Why Is Avid Bioservices (CDMO) Stock Down 30% Today?(Investorplace)
- 2024-03-06 16:32
- 2024-03-06 16:31
- 2024-03-06 10:58
- 2024-03-06 03:32
Page 1 of 5
previousnext